Evolution of drug regulations and regulatory innovation for anticancer drugs in China.
Liu Y, Zhang N, Xie C, Jiang Y, Qin Y, Zhou L, Fan Y, Ren L, Yin C, Yang H, Xie W, Zhai Q, Li G, Chen H, Chen X.
Liu Y, et al. Among authors: xie w, xie c.
Acta Pharm Sin B. 2022 Dec;12(12):4365-4377. doi: 10.1016/j.apsb.2022.08.004. Epub 2022 Aug 13.
Acta Pharm Sin B. 2022.
PMID: 36561995
Free PMC article.
Review.